Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

PRODUCT NAME

URANYL NITRATE

NFPA

PRODUCT USE

This radioactive material may be supplied in a variety of package types and may exhibit a
range of specific activities. This document is intended to describe one such material
thought to be representative of a typical commercial product. Laboratory reagent; source
of uranium dioxide; intermediate for extraction of uranium into non- aqueous solvents;
porcelain glazing; intensifier in photography.

SYNONYMS

UO2(NO3)2, "formerly UN2981", N2-O8-U, "uranium, bis(nitrato-O-O')dioxo-", "uranium,
bis(nitrato-O-O')dioxo-", "uranium (VI) dioxide dinitrate", "uranium (VI) dioxide
dinitrate", "uranium (VI) oxynitrate", "uranium (VI) oxynitrate", UNH, uranylnitrate,
"dinitratodioxo uranium", "yellow salt"

Section 2 - HAZARDS IDENTIFICATION

CANADIAN WHMIS SYMBOLS

None

EMERGENCY OVERVIEW

RISK

Contact with combustible material may cause fire.
Danger of cumulative effects.
Irritating to eyes.
Limited evidence of a carcinogenic effect.
Very toxic by inhalation and if swallowed.
Toxic to aquatic organisms, may cause long- term adverse effects in the aquatic
environment.

POTENTIAL HEALTH EFFECTS

ACUTE HEALTH EFFECTS

SWALLOWED

  Severely toxic effects may result from the accidental ingestion of the material; animal experiments indicate that ingestion of less than 5 gram may be fatal or may produce serious damage to the health of the individual.  The kidney and liver can be damaged by uranium, causing excessive acid and urea in the blood and generalized ill health.  Uranium compounds are not highly poisonous in low concentrations but may be lethal in high concentrations.  The substance and/or its metabolites may bind to hemoglobin inhibiting normal uptake of oxygen. This condition, known as "methemoglobinemia", is a form of oxygen starvation (anoxia).  Symptoms include cyanosis (a bluish discoloration skin and mucous membranes) and breathing difficulties. Symptoms may not be evident until several hours after exposure.  At about 15% concentration of blood methemoglobin there is observable cyanosis of the lips, nose and earlobes. Symptoms may be absent although euphoria, flushed face and headache are commonly experienced. At 25-40%, cyanosis is marked but little disability occurs other than that produced on physical exertion. At 40-60%, symptoms include weakness, dizziness, lightheadedness, increasingly severe headache, ataxia, rapid shallow respiration, drowsiness, nausea, vomiting, confusion, lethargy and stupor. Above 60% symptoms include dyspnea, respiratory depression, tachycardia or bradycardia, and convulsions. Levels exceeding 70% may be fatal.  

EYE

  This material can cause eye irritation and damage in some persons.  The eye is particularly sensitive to radioactivity. A single dose of 1 Gy can cause inflammation of the conjunctiva and cornea. It is unlikely that a dose sufficient to cause radiation sickness would occur if only the eyes were involved. However, if eye damage caused by ionizing radiation occurs, it should be assumed that other parts of the body are involved.  

SKIN

  Skin contact with the material may damage the health of the individual; systemic effects may result following absorption.  There is some evidence to suggest that this material can cause inflammation of the skin on contact in some persons.  Open cuts, abraded or irritated skin should not be exposed to this material.  Entry into the blood-stream, through, for example, cuts, abrasions or lesions, may produce systemic injury with harmful effects. Examine the skin prior to the use of the material and ensure that any external damage is suitably protected.  All soluble uranium compounds are lethal when applied at sufficiently high concentrations in a single dose to the skin of rabbits; insoluble salts do not cause death and cause no signs of poisoning.  

INHALED

  Inhalation of vapors, aerosols (mists, fumes) or dusts, generated by the material during the course of normal handling, may produce severely toxic effects; these may be fatal.  There is some evidence to suggest that the material can cause respiratory irritation in some persons. The body's response to such irritation can cause further lung damage.  A whole body dose of 2-10 Gray may cause loss of appetite, tiredness, nausea and vomiting,  most severe after 6-12 hours. After this subsides a gross disturbance in blood cell distribution occurs with loss of white blood cells and platelets over weeks. The activity of bone marrow may become so depressed that overwhelming infections can occur and cause death. A dose of 4 Gray can lead to damage of the bowel lining, causing untreatable nausea, vomiting and diarrhea, which may result in severe dehydration, collapse and death. Although repair of the damage may occur, failure of blood cell production can ensue. At 6 Gray, damage to the blood cell production and digestive systems can be fatal. Whole body doses of 30 Gray can cause nausea, vomiting, listlessness, drowsiness, weakness, tremors, convulsions, inco-ordination and death within hours. The reproductive organs are particularly sensitive to radiation. A does of 0.3 Gray can cause temporary loss of fertility in men; there may be cessation of periods in women.  Dusts and mists containing uranium compounds are highly toxic and more so if inhaled rather than ingested. A single large dose can produce radiation sickness. Whole body doses of 2 to 10 Gray may cause loss of appetite, tiredness, nausea and vomiting. Soluble compounds are more dangerous and the effects on the body vary. Small particles may lodge in the lungs; larger ones tend to be swallowed. After a delay of up to several days, blood disturbances including loss of white blood cells and platelets may occur. Gastrointestinal symptoms can be severe with intense nausea, vomiting and diarrhea leading to dehydration and death. At doses up to 6 Gray survival is inversely proportional to dose. At 30 Gray, nausea, vomiting, listlessness and drowsiness, with tremors, weakness, convulsions, inco-ordination and death occurring within hours. Very small doses (0.3 Gray) can cause loss of male fertility; periods may stop in women.  

CHRONIC HEALTH EFFECTS

  Repeated or long-term occupational exposure is likely to produce cumulative health effects involving organs or biochemical systems.  There has been concern that this material can cause cancer or mutations, but there is not enough data to make an assessment.  If absorbed in the body, uranium can be a hazard due to its radioactivity (alpha and gamma radiation). Uranium accumulates in the bones and can cause cancers there. It also increases the risk of developing cancers of the lung, central nervous system, and lymph. Uranium can cause kidney failure and damage the liver. It also causes skin inflammation, conjunctivitis and cataracts. Soluble compounds can be toxic if inhaled. Insoluble uranium compounds can accumulate in the lungs, causing scarring. Uranium can cause a wide range of genetic damage; if the reproductive cells are affected, there may be no signs until the damage is inherited to the next generation.  A single large or prolonged low exposure to radiation can cause delayed effects, including blood cancers, genetic disorders, shortened lifespan and cataracts. Leukemia is the most common cancer caused; cancers of the thyroid, bone, lung (due to radioactive particle deposits) and skin are also seen. Many and varied genetic changes can occur; if they affect cells of the reproductive system, they may only display themselves after being inherited.  Long term exposure to high dust concentrations may cause changes in lung function i.e. pneumoconiosis; caused by particles less than 0.5 micron penetrating and remaining in the lung. Prime symptom is breathlessness; lung shadows show on X-ray.